Compass Pathways deals with psychedelics and their promising properties when it comes to the treatment of mental illnesses.
Purple Zone: Safe Entry
Green Zone: Risk Entry
76% potential return.
Citron Research has a $100 PT.
Citigroup has a $67 PT.
Bullish MACD cross
Consolidating for the past 113 days
Purple Zone: Safe Entry
Green Zone: Risk Entry
76% potential return.
Citron Research has a $100 PT.
Citigroup has a $67 PT.
Bullish MACD cross
Consolidating for the past 113 days
交易進行
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。